Serum Troponin Level in Acute Ischemic Stroke Identifies Patients with Visceral Infarcts.
暂无分享,去创建一个
K. Furie | M. Elkind | M. Jayaraman | M. Atalay | S. Yaghi | Michael E. Reznik | M. Paciaroni | Andrew D Chang | K. Dakay | S. Cutting | Tina Burton | Brian C. Mac Grory | L. Wendell | N. S. Potter | Idrees Azher | A. Mahta | Shyam S. Rao | Ashutosh Kaushal | Bradford B. Thompson | N. Potter | B. M. Mac Grory
[1] R. Kronmal,et al. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods , 2018, International journal of stroke : official journal of the International Stroke Society.
[2] Hooman Kamel,et al. Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source , 2018, Stroke.
[3] H. Kamel,et al. Relationship Between Visceral Infarction and Ischemic Stroke Subtype , 2018, Stroke.
[4] H. Kamel,et al. Association Between Troponin Levels and Embolic Stroke of Undetermined Source , 2017, Journal of the American Heart Association.
[5] H. Kamel,et al. Atrial cardiopathy: a mechanism of cryptogenic stroke , 2017, Expert review of cardiovascular therapy.
[6] S. Yusuf,et al. Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes , 2015, Circulation.
[7] A. Folsom,et al. Troponin T, N-Terminal Pro–B-Type Natriuretic Peptide, and Incidence of Stroke: The Atherosclerosis Risk in Communities Study , 2013, Stroke.
[8] R. Kronmal,et al. Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy , 2013, Stroke.